These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
524 related articles for article (PubMed ID: 19407553)
1. Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status. Hublarova P; Hrstka R; Rotterova P; Rotter L; Coupkova M; Badal V; Nenutil R; Vojtesek B Int J Gynecol Cancer; 2009 Apr; 19(3):321-5. PubMed ID: 19407553 [TBL] [Abstract][Full Text] [Related]
2. HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study. Pastuszak-Lewandoska D; Bartosińska-Dyc A; Migdalska-Sęk M; Czarnecka KH; Nawrot E; Domańska D; Szyłło K; Brzeziańska E Med Oncol; 2014 Mar; 31(3):842. PubMed ID: 24436016 [TBL] [Abstract][Full Text] [Related]
3. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection. Li B; Hu Y; Ye F; Li Y; Lv W; Xie X Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590 [TBL] [Abstract][Full Text] [Related]
4. A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia. Piyathilake CJ; Macaluso M; Alvarez RD; Chen M; Badiga S; Edberg JC; Partridge EE; Johanning GL Cancer; 2011 Mar; 117(5):957-63. PubMed ID: 20945322 [TBL] [Abstract][Full Text] [Related]
5. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions. Cricca M; Morselli-Labate AM; Venturoli S; Ambretti S; Gentilomi GA; Gallinella G; Costa S; Musiani M; Zerbini M Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661 [TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia. Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting? Boulet GA; Benoy IH; Depuydt CE; Horvath CA; Aerts M; Hens N; Vereecken AJ; Bogers JJ Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2992-9. PubMed ID: 19861526 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus typing and viral gene expression analysis for the triage of women with abnormal results from papanicolaou test smears to colposcopy. Antonishyn NA; Horsman GB; Kelln RA; Severini A Arch Pathol Lab Med; 2009 Oct; 133(10):1577-86. PubMed ID: 19792047 [TBL] [Abstract][Full Text] [Related]
9. Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16. Hong D; Liu J; Hu Y; Lu X; Li B; Li Y; Hu D; Lu W; Xie X; Cheng X BMC Cancer; 2017 Feb; 17(1):136. PubMed ID: 28202002 [TBL] [Abstract][Full Text] [Related]
10. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955 [TBL] [Abstract][Full Text] [Related]
11. [Quantities of human papillomavirus 16 E6 mRNA and its relationship with expression of survivin in cervical cancer]. Liu FY; Xu XM; Liu YZ; Wu YL; Wu DW Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):627-30. PubMed ID: 16202321 [TBL] [Abstract][Full Text] [Related]
12. Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells. Jiang B; Xue M Genet Mol Res; 2015 Sep; 14(3):10473-81. PubMed ID: 26400278 [TBL] [Abstract][Full Text] [Related]
13. Association of elevated E6 oncoprotein with grade of cervical neoplasia using PDZ interaction-mediated precipitation of E6. Sellors JW; Schweizer JG; Lu PS; Liu B; Weigl BH; Cui JF; Peck RB; Lewis K; Lim J; Howard M; Mahoney CW; McAllister L; Berard-Bergery M; Bry C; Labiad YA; Li H; Liu L; Silver J; Chen W; Qiao YL J Low Genit Tract Dis; 2011 Apr; 15(2):169-76. PubMed ID: 21478701 [TBL] [Abstract][Full Text] [Related]
14. Distribution of human papillomavirus 16 E6/E7 variants in cervical cancer and intraepithelial neoplasia in Chinese women. Ding T; Wang X; Ye F; Cheng X; Lu W; Xie X Int J Gynecol Cancer; 2010 Nov; 20(8):1391-8. PubMed ID: 21051983 [TBL] [Abstract][Full Text] [Related]
15. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043 [TBL] [Abstract][Full Text] [Related]
16. Gene expression profiles are altered in human papillomavirus-16 E6 D25E-expressing cell lines. Jang M; Rhee JE; Jang DH; Kim SS Virol J; 2011 Sep; 8():453. PubMed ID: 21943319 [TBL] [Abstract][Full Text] [Related]
17. Distribution of human papillomavirus type 16 E6 and E7 gene variants in the progression of cervical dysplasia in Korean women. Lee CW; Bae JH; Lee SJ; Ho EM; Lee IH; Park YG; Park JS J Obstet Gynaecol Res; 2011 Oct; 37(10):1320-6. PubMed ID: 21535311 [TBL] [Abstract][Full Text] [Related]
18. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Häfner N; Driesch C; Gajda M; Jansen L; Kirchmayr R; Runnebaum IB; Dürst M Oncogene; 2008 Mar; 27(11):1610-7. PubMed ID: 17828299 [TBL] [Abstract][Full Text] [Related]
19. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III. Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ Tumori; 2007; 93(6):572-9. PubMed ID: 18338492 [TBL] [Abstract][Full Text] [Related]
20. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3. Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]